ArticleScientific reports2026
Route-dependent dissemination with conserved blood-tumor barrier ultrastructure in intracranial metastasis models.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The dissemination route of brain metastases dictates their spatiotemporal distribution, but whether it alters the ultrastructural state of the blood-tumor barrier remains unresolved. Here, we compared a modified hematogenous dissemination model that minimizes extracranial signal confounds with a direct intracranial inoculation model. The hematogenous model produced multifocal brain lesions, whereas the intracranial model formed unifocal masses. Longitudinal bioluminescence imaging revealed significantly different growth rates between models, yet no statistically significant difference in overall survival was detected under the current cohort sizes and humane endpoints. Critically, exploratory transmission electron microscopy at the tumor-brain interface revealed a conserved pathological phenotype of the blood-tumor barrier in established lesions, irrespective of the seeding route. This pattern was characterized by endothelial cell swelling, a discontinuous basement membrane, and retraction of astrocytic end-feet. These findings suggest that while the seeding route determines the macroscopic pattern of disease, the established brain microenvironment imposes a stereotyped mode of neurovascular unit failure. This work provides a methodologically refined platform for studying brain metastasis and presents direct ultrastructural evidence consistent with a conserved blood-tumor barrier pathology, outlining a testable conceptual framework. These hypothesis-generating ultrastructural observations, derived from representative specimens, warrant quantitative validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.